https://www.selleckchem.com/pr....oducts/ccg-203971.ht
Invasive fungal infections, especially candidemia and invasive candidiasis, cause significant morbidity and mortality. The epidemiology of candida infections have changed dramatically due to an increase in risk factors associated with the development of infection and the emergence of resistant isolates such as and . This has prompted the search for novel and effective antifungals. The results of studies evaluating the activity of ibrexafungerp against species are reviewed and the pharmacokinetic/pharmacodynamic properties are highlig
Kao
Komentar
Udio
